• In March 2026, Microvast Holdings, Inc. reported fourth-quarter 2025 sales of US$96.4 million, full-year sales of US$427.52 million, a sharply lower annual net loss of US$29.22 million, and issued 2026 guidance pointing to continued revenue growth while citing tariff, regulatory, and geopolitical headwinds.
• On the same day, auditor Deloitte Touche Tohmatsu CPA Ltd issued an unqualified opinion but raised doubt about Microvast’s ability to continue as a going concern, highlighting a tension between operational progress and financing and liquidity risks.
• With the auditor’s going concern warning now public, we’ll examine how this development reshapes Microvast’s earlier growth-focused investment narrative.

Uncover the next big thing with 32 elite penny stocks that balance risk and reward.

Microvast Holdings Investment Narrative Recap

To own Microvast today, you have to believe its advanced EV and energy storage batteries can translate record 2025 sales of US$427.52 million into a sustainably self-funded business. The latest results show improved profitability, but Deloitte’s going concern warning shifts the near term focus to refinancing and liquidity as the key catalyst and risk. That opinion is material, because it puts balance sheet strength at the center of the story, ahead of capacity expansion or new products.

The most relevant announcement is the 10 K filing where Deloitte issued an unqualified opinion while questioning Microvast’s ability to continue as a going concern. Set against management’s 2026 guidance for continued revenue growth, it creates a clear split between operational progress and financing risk. For anyone watching catalysts, that audit language may now matter more than product launches, plant ramps, or guidance beats when assessing what could move the stock next.

Yet beneath the record revenue and improving net loss, the auditor’s doubt about Microvast’s ability to continue as a going concern is something investors should be aware of...

Microvast Holdings' narrative projects $726.7 million revenue and $78.9 million earnings by 2028. This requires 19.8% yearly revenue growth and a $192.2 million earnings increase from -$113.3 million today.

Uncover how Microvast Holdings' forecasts yield a $6.50 fair value, a 278% upside to its current price.

Exploring Other Perspectives

The most cautious analysts were already warning that rising geopolitical and regulatory risks could unsettle Microvast’s growth, even as they still penciled in about US$712 million of revenue and US$56 million of earnings by 2028, so this new going concern warning may push you to reassess which version of the story you find more convincing.

Explore 7 other fair value estimates on Microvast Holdings - why the stock might be worth over 7x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Microvast Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Microvast Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Microvast Holdings' overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Invest in the nuclear renaissance through our list of 87 elite nuclear energy infrastructure plays powering the global AI revolution.
• This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.